ArticleMarine drugs2026

Comprehensive Pharmacokinetics of the Marine-Derived PDE4 Inhibitor LY104 and Its Major Metabolite M1 in Rats: A Validated LC-MS/MS Method with Sex Comparison, Multiple-Dose, Protein Binding, Metabolic Stability, and Excretion Studies.

Xiaochen Niu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.